Dr. Martens Plc (GB:DOCS) has released an update.
Dr. Martens plc has reported a share transaction by CEO Kenny Wilson under its Share Incentive Plan, where Wilson purchased 190 shares at 79.25p each and was awarded an equal number of matching shares for no additional cost. The transaction, which took place on the London Stock Exchange and outside a trading venue on May 13, 2024, falls under the purview of the UK Market Abuse Regulation. This move demonstrates the ongoing commitment of Dr. Martens’ management to invest in the company’s future.
For further insights into GB:DOCS stock, check out TipRanks’ Stock Analysis page.
